Fig. 2From: Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunitiesThe therapeutic capacity of MSC-derived exosomes in lung disorders. The MSC exosomes could elicit desired therapeutic outcomes in transplanted patients upon administration by intravenous (IV) or inhalation route possibly mediated by their anti-inflammatory, immunomodulatory, pro-angiogenic, and also anti-fibrotic properties. MSCs; mesenchymal stem/stromal cellsBack to article page